Spending on postapproval drug safety

Health Affairs
David B RidleyKevin A Schulman

Abstract

Withdrawals of high-profile pharmaceuticals have focused attention on post-approval safety surveillance. There have been no systematic assessments of spending on postapproval safety. We surveyed drug manufacturers regarding safety efforts. Mean spending on postapproval safety per company in 2003 was 56 million dollars (0.3 percent of sales). Assuming a constant safety-to-sales ratio, we estimated that total spending on postapproval safety by the top twenty drug manufacturers was 800 million dollars in 2003. We also examined, using regression analysis, the relationship between the number of safety personnel and the number of initial adverse-event reports. This study offers information for the debate on proposed changes to safety surveillance.

References

Mar 24, 1993·JAMA : the Journal of the American Medical Association·R L WoosleyR A Gillis
Feb 28, 2003·Journal of Health Economics·Joseph A DiMasiHenry G Grabowski
Mar 20, 2003·Pharmacoepidemiology and Drug Safety·Robert Gross, Brian L Strom
Feb 7, 2004·Pharmacoepidemiology and Drug Safety·UNKNOWN Centers for Education and Research on Therapeutics Risk Assessment Workshop
Oct 2, 2004·The New England Journal of Medicine·Anne Trontell
Oct 8, 2004·The New England Journal of Medicine·Garret A Fitzgerald
Nov 24, 2004·Journal of Health Economics·Mary K Olson
Mar 25, 2005·The New England Journal of Medicine·Susan Okie
Mar 9, 2006·Health Affairs·Henry G Grabowski, Y Richard Wang

❮ Previous
Next ❯

Citations

Jun 19, 2012·European Journal of Clinical Pharmacology·Hans C EbbersHubert G M Leufkens
Oct 5, 2011·American Journal of Pharmaceutical Education·Sirisha KalariAparna Mohan
Mar 9, 2006·Health Affairs·David B RidleyJeffrey L Moe
Apr 4, 2013·Clinical Pharmacology and Therapeutics·J C BouvyM A Koopmanschap

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Health Affairs
David B RidleyJeffrey L Moe
The Journal of Economic Perspectives : a Journal of the American Economic Association
Ernst R Berndt
© 2021 Meta ULC. All rights reserved